NSUN4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.351600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.724000E-01
Normal-vs-Stage2
1.941170E-01
Normal-vs-Stage3
6.621100E-03
Normal-vs-Stage4
9.446300E-02
Stage1-vs-Stage2
3.871200E-01
Stage1-vs-Stage3
4.380100E-03
Stage1-vs-Stage4
1.452410E-02
Stage2-vs-Stage3
1.994010E-02
Stage2-vs-Stage4
5.720800E-03
Stage3-vs-Stage4
2.448500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.316200E-01
Normal-vs-AfricanAmerican
4.239000E-01
Normal-vs-Asian
2.679600E-01
Caucasian-vs-AfricanAmerican
6.589000E-01
Caucasian-vs-Asian
8.159200E-01
AfricanAmerican-vs-Asian
8.119200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.591030E-01
Normal-vs-Female
3.413800E-01
Male-vs-Female
2.394000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.126600E-01
Normal-vs-Age(41-60Yrs)
3.428000E-01
Normal-vs-Age(61-80Yrs)
2.054200E-01
Normal-vs-Age(81-100Yrs)
1.475610E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.871200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.180600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.038400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.760300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.077180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.558000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.415800E-02
Normal-vs-Daily Drinker
8.221900E-02
Normal-vs-Weekly Drinker
1.216830E-01
Normal-vs-Occasional Drinker
7.541600E-01
Normal-vs-Social Drinker
2.834200E-01
Non Drinker-vs-Daily Drinker
8.677800E-01
Non Drinker-vs-Weekly Drinker
7.945000E-01
Non Drinker-vs-Occasional Drinker
1.917890E-02
Non Drinker-vs-Social Drinker
8.610100E-02
Daily Drinker-vs-Weekly Drinker
9.056400E-01
Daily Drinker-vs-Occasional Drinker
3.487800E-02
Daily Drinker-vs-Social Drinker
1.138230E-01
Weekly Drinker-vs-Occasional Drinker
8.866000E-02
Weekly Drinker-vs-Social Drinker
1.947380E-01
Occasional Drinker-vs-Social Drinker
4.509000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.616400E-01
Normal-vs-Grade 2
5.820000E-01
Normal-vs-Grade 3
6.151800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.894200E-01
Grade 1-vs-Grade 3
5.773600E-01
Grade 1-vs-Grade 4
3.616400E-01
Grade 2-vs-Grade 3
4.068200E-01
Grade 2-vs-Grade 4
5.820000E-01
Grade 3-vs-Grade 4
6.151800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.456830E-01
Normal-vs-NonDiabetic
1.800990E-01
Diabetic-vs-NonDiabetic
6.221800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.863400E-01
Normal-vs-NoPancreatitis
1.898580E-01
Pancreatitis-vs-NoPancreatitis
5.912600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.443200E-01
Normal-vs-N1
2.128000E-01
N0-vs-N1
8.179000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.786600E-01
Normal-vs-TP53-NonMutant
3.980800E-01
TP53-Mutant-vs-TP53-NonMutant
7.488200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
